[Abdominal and retroperitoneal abscesses in a patient with bladder carcinoma receiving BCG therapy].
Fernández
José María
JM
Cartón
José Antonio
JA
Rodríguez
Azucena
A
Asensi
Víctor
V
D018784:Abdominal Abscess / Q000139:chemically induced* / Q000382:microbiology; D000276:Adjuvants, Immunologic / Q000009:adverse effects* / Q000627:therapeutic use; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy; D006801:Humans; D008297:Male; D009163:Mycobacterium bovis / Q000302:isolation & purification; D012187:Retroperitoneal Space; D014376:Tuberculosis / Q000139:chemically induced* / Q000382:microbiology; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy
D000276:Adjuvants, Immunologic; D001500:BCG Vaccine